We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Study Shows ICD Patients Unaware of Driving Restrictions

By HospiMedica International staff writers
Posted on 10 Sep 2019
Nearly one-third of patients with an implantable cardioverter defibrillator (ICD) resume driving despite it being medically contraindicated, claims a new study.

Researchers at Gentofte University Hospital (Hellerup, Denmark) conducted a study to investigate adherence to driving restrictions among a nationwide cohort of ICD patients. More...
To do so, a questionnaire was sent to 3,913 adults who received a first-time ICD between 2013 and 2016. Additional data was obtained from national registries. Of the 2,741 respondents, 92% had a valid driving license at the time of ICD implantation, and 7% also had a professional driver’s license. In all, more than 30% of ICD patients, including professional drivers, resumed driving during the banned period.

The answers revealed that up to 60% of the patients could not recall being informed of any restriction, and that those who claimed amnesia were three times more likely to drive when banned. Men were 50% more likely to drive while banned, and patients 60 years and older were 20% more likely to drive while banned than younger ICD patients. Being the only driver in the household was linked with a 30% greater likelihood of driving while banned than those who lived with other people who could drive. The study was presented at the annual European Society of Cardiology (ESC) Congress, held during August-September 2019 in Paris (France).

“Information is the key word here. These driving restrictions are worthless if we do not tell patients about them. On the other hand, patients do not remember everything they are told, and if you have recently survived a cardiac arrest, driving restrictions might not be your biggest concern,” said lead author Jenny Bjerre, MD. “Better communication is required, for example by repeating the information, also in writing, explaining the rationale behind the restrictions, and including family members in the discussions.”

The ESC recommends a permanent ban on all professional driving following ICD implantation, and that driving for personal use be banned for four weeks for primary prevention, and three months for secondary prevention; if the ICD delivers a shock to correct an arrhythmia, an additional three-month driving ban is implemented. The penalty for driving while banned depends on national legislation. In Denmark, there is a risk of legal prosecution and/or insurance-related consequences if an ICD patient is involved in a traffic accident during a period with a documented medical driving restriction.

Related Links:
Gentofte University Hospital


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Hypodermic Syringe
SurTract™ Safety Syringe
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Half-matched bone marrow transplant expands access to curative treatment for children and young adults with severe aplastic anemia. (Photo courtes of Margarita Dionysiou using Bio Render)

Half-Matched Family Donors Could Expand Transplant Access for Severe Aplastic Anemia

Severe aplastic anemia is a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells, leaving children and young adults vulnerable to anemia, infection, and bleeding.... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.